|
WO2021062059A1
|
|
Methods of isolating cells from placental tissue
|
|
WO2020060934A1
|
|
Okra-derived antiviral composition and uses thereof
|
|
WO2019226920A1
|
|
Molecules derived from gram-positive bacteria
|
|
CN111032053A
|
|
DEFA 5-targeting antibodies and assays for diagnosis and treatment of inflammatory bowel disease
|
|
AU2018266135A1
|
|
Hydroxyurea to enhance sperm cells
|
|
CA3056911A1
|
|
Methods for diagnosing and treating inflammatory bowel disease
|
|
WO2018112124A1
|
|
Antiviral agents
|
|
BR112019005935A2
|
|
bacterial inhibitors
|
|
WO2018052848A1
|
|
Okra extract as a substitute for cervical mucus
|
|
MX2019001770A
|
|
Inhibitors of intracellular invasion.
|
|
AU2017286544A1
|
|
Modulation of the nitric oxide synthase pathway for oral health
|
|
US7026305B2
|
|
Anti-HIV agents with dual sites of action
|
|
US3382147A
|
|
Compositions and methods for modifying and modulating the activity of central nervous system depressants
|
